Actively Recruiting
Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant
Led by Aesculap AG · Updated on 2026-05-08
150
Participants Needed
4
Research Sites
339 weeks
Total Duration
On this page
Sponsors
A
Aesculap AG
Lead Sponsor
R
Raylytic GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.
CONDITIONS
Official Title
Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Indication for a primary medial unicompartmental knee endoprosthesis
- Both cruciate ligaments intact
- Lateral ligaments intact
- Leg axis amenable to passive correction
- Varus deformity under 15°
- Bending capability of at least 90°
- Extension deficit no greater than 5-10°
- Written informed consent of patient
- Kellgran & Lawrence Score > II (only straight or varus)
- Patients with moderate radiological symptoms
- Patients without clinical symptoms
You will not qualify if you...
- Pregnancy
- Patient age <18 and >75 years
- BMI ≥ 40
- High risk patients ASA > III
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Oberlinklinik gGmbH
Potsdam, Brandenburg, Germany, 14482
Not Yet Recruiting
2
Lukas Krankenhaus
Bünde, North Rhine-Westphalia, Germany, 32257
Not Yet Recruiting
3
St. Vincenz Hospital Brakel
Brakel, Germany, 33034
Actively Recruiting
4
LMU Großhadern
München, Germany, 81377
Not Yet Recruiting
Research Team
P
Petra Wain
CONTACT
S
Stefan Maenz, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here